Department of Neurology, Neurological Institute (S.M.), Cleveland Clinic, OH.
Center for Populations Health Research, Department of Quantitative Health Sciences (D.B., J.E.D.), Cleveland Clinic, OH.
Stroke. 2024 Oct;55(10):2472-2481. doi: 10.1161/STROKEAHA.124.047071. Epub 2024 Sep 5.
Existing data suggested a rural-urban disparity in thrombolytic utilization for ischemic stroke. Here, we examined the use of guideline-recommended stroke care and outcomes in rural hospitals to identify targets for improvement.
This retrospective cohort study included patients (aged ≥18 years) treated for acute ischemic stroke at Get With The Guidelines-Stroke hospitals from 2017 to 2019. Multivariable mixed-effect logistic regression was used to compare thrombolysis rates, speed of treatment, secondary stroke prevention metrics, and outcomes after adjusting for patient- and hospital-level characteristics and stroke severity.
Among the 1 127 607 patients admitted to Get With The Guidelines-Stroke hospitals in 2017 to 2019, 692 839 patients met the inclusion criteria. Patients who presented within 4.5 hours were less likely to receive thrombolysis in rural stroke centers compared with urban stroke centers (31.7% versus 43.5%; adjusted odds ratio [aOR], 0.72 [95% CI, 0.68-0.76]) but exceeded rural nonstroke centers (22.1%; aOR, 1.26 [95% CI, 1.15-1.37]). Rural stroke centers were less likely than urban stroke centers to achieve door-to-needle times of ≤45 minutes (33% versus 44.7%; aOR, 0.86 [95% CI, 0.76-0.96]) but more likely than rural nonstroke centers (aOR, 1.24 [95% CI, 1.04-1.49]). For secondary stroke prevention metrics, rural stroke centers were comparable to urban stroke centers but exceeded rural nonstroke centers (aOR of 1.66, 1.94, 2.44, 1.5, and 1.72, for antithrombotics within 48 hours of admission, antithrombotics at discharge, anticoagulation for atrial fibrillation/flutter, statin treatment, and smoking cessation, respectively). In-hospital mortality was similar between rural and urban stroke centers (aOR, 1.11 [95% CI, 0.99-1.24]) or nonstroke centers (aOR, 1.00 [95% CI, 0.84-1.18]).
Rural hospitals had lower thrombolysis utilization and slower treatment times than urban hospitals. Rural stroke centers provided comparable secondary stroke prevention treatment to urban stroke centers and exceeded rural nonstroke centers. These results reveal important opportunities and specific targets for rural health equity interventions.
现有数据表明,在缺血性脑卒中的溶栓治疗方面存在城乡差异。在此,我们研究了农村医院中指南推荐的脑卒中治疗方法和结果,以确定需要改进的目标。
本回顾性队列研究纳入了 2017 年至 2019 年在 Get With The Guidelines-Stroke 医院接受急性缺血性脑卒中治疗的患者(年龄≥18 岁)。采用多变量混合效应逻辑回归比较了溶栓率、治疗速度、二级卒中预防指标以及调整患者和医院水平特征和卒中严重程度后的结果。
在 2017 年至 2019 年接受 Get With The Guidelines-Stroke 医院治疗的 1127607 名患者中,有 692839 名患者符合纳入标准。与城市卒中中心相比,农村卒中中心就诊 4.5 小时内接受溶栓治疗的患者比例较低(31.7%比 43.5%;调整后的优势比[OR],0.72[95%CI,0.68-0.76]),但高于农村非卒中中心(22.1%;OR,1.26[95%CI,1.15-1.37])。农村卒中中心与城市卒中中心相比,实现门到针时间≤45 分钟的可能性较小(33%比 44.7%;OR,0.86[95%CI,0.76-0.96]),但高于农村非卒中中心(OR,1.24[95%CI,1.04-1.49])。对于二级卒中预防指标,农村卒中中心与城市卒中中心相当,但优于农村非卒中中心(抗栓治疗在入院后 48 小时内、出院时、心房颤动/扑动抗凝、他汀类药物治疗和戒烟的 OR 分别为 1.66、1.94、2.44、1.5 和 1.72)。农村和城市卒中中心(OR,1.11[95%CI,0.99-1.24])或非卒中中心(OR,1.00[95%CI,0.84-1.18])的院内死亡率相似。
农村医院的溶栓使用率和治疗时间均低于城市医院。农村卒中中心提供的二级卒中预防治疗与城市卒中中心相当,优于农村非卒中中心。这些结果揭示了农村卫生公平干预的重要机会和具体目标。